This site is new - feedback and suggestions welcome via GitHub issues.

#pharmacokinetics — Wednesday, June 03, 2026 (21 items)

0 ℹ Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML. (journals.asm.org) robot Joisten CS … Stemler J Antimicrobial Agents and Chemotherapy 2026-06-03 #pharmacokinetics #toxicity #drug-drug interaction #leukemia
0 ℹ Time-varying voriconazole clearance during extracorporeal membrane oxygenation. (journals.asm.org) robot Yusuff H … Mulla H Antimicrobial Agents and Chemotherapy 2026-06-03 #pharmacokinetics #modeling #infection #metabolism #aspergillosis
0 ℹ Plasma and intrapulmonary pharmacokinetics of ceftibuten and ledaborbactam in healthy male and female adults. (journals.asm.org) robot Rodvold KA … McGovern PC Antimicrobial Agents and Chemotherapy 2026-06-03 #pharmacokinetics #infection #amr #sequencing
0 ℹ Population pharmacokinetics and exposure-response analysis of levofloxacin in Chinese pediatric patients with severe refractory Mycoplasma pneumoniae pneumonia. (journals.asm.org) robot Tao X … Lv M Antimicrobial Agents and Chemotherapy 2026-06-03 #pharmacokinetics #modeling #dosing #infection #pediatric
0 ℹ Population pharmacokinetic modeling and simulation-informed ceftazidime dosing in Chinese neonates using quantitative dried blood spot micro-sampling. (journals.asm.org) robot Yin Q … Chen Q Antimicrobial Agents and Chemotherapy 2026-06-03 #pharmacokinetics #modeling #dosing #infection #neonates
0 ℹ Model-informed precision dosing of vancomycin in children 3 months to 18 years of age using Australia-wide data. (journals.asm.org) robot Xu H … Gwee A Antimicrobial Agents and Chemotherapy 2026-06-03 #pharmacokinetics #modeling #dosing #infection
0 ℹ Evaluation of the cytochrome P450-mediated drug interaction profile of olorofim. (journals.asm.org) robot Cornelissen K … Bruggemann R Antimicrobial Agents and Chemotherapy 2026-06-03 #pharmacokinetics #modeling #antifungal #drug-drug interaction
0 ℹ Population pharmacokinetics and safety of continuous oxacillin in preterm and term neonates and infants. (journals.asm.org) robot Lee A … Arrieta AC Antimicrobial Agents and Chemotherapy 2026-06-03 #pharmacokinetics #dosing #amr #sepsis #neonatal
0 ℹ A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection. (academic.oup.com) robot Khoo SH … Griffiths G Journal of Antimicrobial Chemotherapy 2026-06-03 #pharmacokinetics #covid-19 #clinical trial #antiviral #safety
0 ℹ The impact of an ex vivo paediatric renal replacement therapy circuit on antimicrobial concentrations. (academic.oup.com) robot Cree ML … Roberts JA Journal of Antimicrobial Chemotherapy 2026-06-03 #pharmacokinetics #amr #clearance #renal replacement therapy
0 ℹ Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients. (academic.oup.com) robot Cojutti PG … Pea F Journal of Antimicrobial Chemotherapy 2026-06-03 #pharmacokinetics #infection #amr #antibiotic #febrile neutropenia
0 ℹ Crushed posaconazole delayed-release tablets via enteric feeding tube administration: practical considerations for clinicians. (academic.oup.com) robot Bhattarai N … Stevens RW Journal of Antimicrobial Chemotherapy 2026-06-03 #pharmacokinetics #antifungal #drug delivery #bioavailability
0 ℹ Exposure to azithromycin and the effect of co-administration of rifampicin in patients with non-tuberculous mycobacterial disease. (academic.oup.com) robot Rodgers MP … Aarnoutse RE Journal of Antimicrobial Chemotherapy 2026-06-03 #pharmacokinetics #infection #therapeutics #drug-drug interaction
0 ℹ Pharmacokinetics and pharmacodynamics of cefoperazone/sulbactam in neutropenic murine lung and thigh infection models against Gram-negative organisms. (academic.oup.com) robot Li X … Zhang J Journal of Antimicrobial Chemotherapy 2026-06-03 #pharmacokinetics #modeling #infection #amr #pharmacodynamics
0 ℹ A multicentre evaluation of pharmacokinetic/pharmacodynamic target attainment of piperacillin and tazobactam and the association with clinical outcomes in critically ill patients with sepsis and septic shock. (academic.oup.com) robot Sulaiman H … Abdul-Aziz MH Journal of Antimicrobial Chemotherapy 2026-06-03 #pharmacokinetics #modeling #dosing #antibiotic #sepsis
0 ℹ Prostatic tissue distribution of gepotidacin in patients undergoing prostatectomy: an ex-vivo microdialysis and pharmacokinetic modelling study. (linkinghub.elsevier.com) robot Al Jalali V … Zeitlinger M Clinical Microbiology and Infection 2026-06-03 #pharmacokinetics #modeling #penetration #microdialysis
0 ℹ A multi-center, open-label, two-part study to investigate the effect of renal function and hemodialysis on the pharmacokinetics of the novel beta-lactamase inhibitor nacubactam. (journals.asm.org) robot Morita J … Bentley D Antimicrobial Agents and Chemotherapy 2026-06-03 #pharmacokinetics #antibiotic #hemodialysis #renal
0 ℹ Pharmacokinetic drug-drug interaction between the COVID-19 3CL protease inhibitor GST-HG171 and itraconazole in healthy subjects. (journals.asm.org) robot Li X … Ding Y Antimicrobial Agents and Chemotherapy 2026-06-03 #pharmacokinetics #covid-19 #drug-drug interaction #protease inhibitor
0 ℹ Evidence of intrapulmonary penetration of nacubactam, a novel beta-lactamase inhibitor, following coadministration of nacubactam with meropenem in healthy adults. (journals.asm.org) robot Morita J … Mallalieu NL Antimicrobial Agents and Chemotherapy 2026-06-03 #pharmacokinetics #amr #pneumonia #antibiotic
0 ℹ Bedaquiline reloading strategies following interruptions during daily dosing. (journals.asm.org) robot Kikstra N … Koele SE Antimicrobial Agents and Chemotherapy 2026-06-03 #pharmacokinetics #modeling #amr #tb
0 ℹ Mass balance study of [(14)C]Netanasvir Phosphate in healthy Chinese participants. (journals.asm.org) robot Zhao C-y … Liu Y-m Antimicrobial Agents and Chemotherapy 2026-06-03 #pharmacokinetics #metabolism #hepatitis c #bioavailability